RESEARCHERS AND BIOTECH COMPANIES PROTEST AGAINST INNOVATIVE MEDICINE DEAL

BY KEITH NUTHALL A GROUP of researchers and biotechnology companies have protested to the European Commission against the European Union's (EU) Innovative Medicines Joint Technology Initiative (IMI), claiming it insufficiently protects their intellectual property. A joint statement was released by the European University Association (EUA); research and technology organisation federation EARTO; German biotechnology association BIO Deutschland; and similar national associations from Belgium, Spain and Sweden. The group claims complex and weak IP protection for ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.